Blueberries Medical Announces Closing of US$1.1 Million Non-Brokered Private Placement, reports 2022 Q3 Financial Results and provides Corporate and Operations Update
28 nov. 2022 17h00 HE
|
Blueberries Medical Corp.
TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical Reports 2022 Q1 Financial Results and Provides Corporate and Operations Update
30 mai 2022 17h23 HE
|
Blueberries Medical Corp.
TORONTO, May 30, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
Blueberries Medical Reports 2021 Q3 Financial Results and Provides Corporate and Operations Update
29 nov. 2021 07h30 HE
|
Blueberries Medical Corp.
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
Blueberries Medical Announces that its wholly subsidiary Blueberries SAS at Bogota, Colombia has made one of the biggest exports of Premium CBD Full Spectrum Oil of all time, scaling up its business to a level that will improve life condition of more than 2.500 patients in Peru
04 oct. 2021 07h30 HE
|
Blueberries Medical Corp.
TORONTO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical Announces Closing of the Acquisition of BBV Labs – A Milestone in its Argentina Project
04 déc. 2020 07h30 HE
|
Blueberries Medical Corp.
TORONTO, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Further to its news releases dated March 26, April 4, and July 2, 2019, Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or...
Blueberries Medical Announces Approval of Nine Psychoactive Strains, Corporate Update
26 oct. 2020 07h30 HE
|
Blueberries Medical Corp.
TORONTO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical to Webcast Live at VirtualInvestorConferences.com on September 10th
08 sept. 2020 07h30 HE
|
Blueberries Medical Corp.
TORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE:BBM) (OTCQB: BBRRF) (FRA: 1OA), (the “Company” or "Blueberries"), a Latin American, licensed producer of medicinal cannabis...
Blueberries Announces Strategic Investor & Closing of $1.0 Million Financing
16 juil. 2020 07h30 HE
|
Blueberries Medical Corp.
TORONTO, July 16, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Blueberries Announces Strategic Partnership with medcann
08 juin 2020 07h30 HE
|
Blueberries Medical Corp.
TORONTO, June 08, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical Granted Cultivation License for up to 37 Acres of Outdoor Production at Second Cultivation Property, Signs Letter of Intent to Commence Low-Cost Outdoor Production
23 avr. 2020 07h30 HE
|
Blueberries Medical Corp.
TORONTO, April 23, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis...